Legal & General Group
NUTX

Legal & General Group’s Nutex Health NUTX Stock Holding History

Legal & General Group’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Buy
3,929
+1,298
+49% +$164K ﹤0.01% 2316
2026
Q1 		$250K Sell
2,631
-1,031
-28% -$126K ﹤0.01% 2500
2025
Q4 		$603K Buy
3,662
+17
+0.5% +$2.25K ﹤0.01% 2364
2025
Q3 		$377K Hold
3,645
– – ﹤0.01% 2520
2025
Q2 		$454K Buy
+3,645
New +$471K ﹤0.01% 2472
2024
Q1 		– Sell
-316
Closed -$8.65K – 3370
2023
Q4 		$8.65K Sell
316
-821
-72% -$25.6K ﹤0.01% 3261
2023
Q3 		$34.1K Hold
1,137
– – ﹤0.01% 2906
2023
Q2 		$71.9K Buy
1,137
+309
+37% +$26.5K ﹤0.01% 2844
2023
Q1 		$125K Buy
828
+52
+7% +$10.5K ﹤0.01% 2727
2022
Q4 		$221K Buy
776
+748
+2,671% +$144K ﹤0.01% 2572
2022
Q3 		$6K Hold
28
– – ﹤0.01% 3393
2022
Q2 		$14K Buy
+28
New +$33K ﹤0.01% 3322

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Legal & General Group's NUTX Position: Q2 2026 in Review

Legal & General Group increased its Nutex Health (NUTX) stake by 49% in Q2 2026, buying an estimated $164K and bringing the position to 3,929 shares worth $671K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

Legal & General Group first reported a position in NUTX in Q2 2022 and has held it in 12 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Legal & General Group held 3,929 shares of Nutex Health worth $671K as of Q2 2026.
  • Legal & General Group bought 1,298 Nutex Health shares in Q2 2026, an estimated $164K.
  • Nutex Health made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2316 holding.
  • Legal & General Group first reported a position in Nutex Health in Q2 2022 and has held it in 12 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.